Search results for: 'detection ad response'
- Related search terms
- detection of pollution carbonaceous particles biologics sales
- detection ad next
- detection ad new
- detection of polluting carbonaceous particles biologics sale
- detection of pollution carbonaceous particle biologics sale
-
20 Jan 2025  |  Global  |  Market Research
Global Cardiac Biomarkers Diagnostics Industry, 2024-2029
Rising Prevalence of CVD and High Sensitivity POCT Driving Transformational Growth in Cardiac Biomarkers Diagnostics
The global cardiac biomarkers diagnostics market is forecast to record robust growth with the increased prevalence of cardiovascular disease (CVD), multiplex biomarkers, advancements in diagnostic testing technology, higher POCT adoption rates, and an intensive focus on preventive healthcare. CVDs are a leading cause of mortality globally, highligh...
$4,950.00 -
17 Jan 2022  |  Global  |  Technology Research
Global Advances in Omics Technologies Enable Future Drug Discovery and Growth Opportunities
Emerging Omics Platforms Drive Precision Drug Discovery
For a long time, drug discovery followed the same path and used conventional analysis methods for proposed targets. Today, changes in technology and the ability to study omics are transforming drug development. Personalized therapy is on the rise and promises to be more effective and efficient in addressing challenges. With growing interest in ...
$4,950.00 -
13 Jan 2025  |  Global  |  Market Outlook
Top 6 Growth Opportunities for the Digital Health Industry, 2025
Mental Health and Generative AI are Driving Transformational Growth
Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive view of industry context, drivers, restraints, and ...
$2,450.00 -
16 Oct 2024  |  Global  |  Frost Radar
Frost Radar™: Digital Pathology, 2024
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
This Frost Radar benchmarks companies offering digital pathology solutions for hospitals and laboratories and discusses opportunities in clinical, pharma, CRO, and research applications. Digital pathology solutions cover all aspects of workflow including sample collection and preparation, image acquisition and integrated image storage, and anal...
$4,950.00 -
25 Apr 2024  |  Global  |  Frost Radar
Frost Radar™: Healthcare Enterprise Managed Cloud Services, 2024
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
In the cloud industry and most other technology-related industries, 2024 will be all about artificial intelligence (AI). Businesses are grappling with how they can leverage AI (particularly generative AI) to meet their goals. Public cloud providers are at the forefront of efforts to accelerate customers AI adoption by developing foundational model...
$4,950.00 -
25 Jun 2019  |  Global  |  Technology Research
Technologies Transforming the Biomanufacturing Landscape
Translating Technology Innovation to Market Competitiveness
Overall Impact of Biomanufacturing Technology Innovations Impact on Unmet Needs Pharmaceutical companies perceive analytical services as important. There is a need for a robust platform that enables the provision of such services. Pharma firms are outsourcing crucial processes and are utilizing services such as analytics, research, process developm...
$4,950.00 -
03 Apr 2023  |  Global  |  Market Outlook
Global Next generation Diagnostics, Outlook 2023
Automation and Digitization Drive the Next Growth Phase Post-COVID-19
As COVID-19 transitions to the endemic phase, automation solutions and smart, connected laboratories will catalyze recovery in the next-generation diagnostics industry. The COVID-19 pandemic left a lot of installed capacity in laboratories and healthcare centers. To take advantage of this situation, it is necessary for industry players to focus on ...
$4,950.00 -
25 Jul 2024  |  Global  |  Technology Research
Engineered Antibody Therapeutics for Cancer
Technology advances and increasing interest from Tier I pharmaceuticals are driving the growth of engineered antibodies
This study analyzes the emergence of engineered antibody therapeutics for cancer, examining the factors driving their adoption. The limitations of monoclonal antibodies have led to an increasing demand for novel formats. Companies are developing multispecific antibodies, such as bispecifics and trispecifics, and antibody fragments, such as Fab and ...
$4,950.00 -
23 Jun 2021  |  Global  |  Technology Research
Global RNA Therapeutics:Technology Growth Opportunities
Advances in RNA Modifications, Formulation, and Stabilization to Drive Growth of RNA Therapeutics
RNA therapeutics is a rapidly expanding area of next-generation biological drugs. RNA is a versatile molecule and naturally regulates gene expression, either by upregulation or downregulation. This function is employed to design novel RNA therapeutics. The fundamentals of RNA therapeutics consists of delivering functional RNA at a target; however, ...
$4,950.00 -
22 Nov 2021  |  Global  |  Technology Research
Technological Advances in RNA Stabilization & Delivery
LNP- and Bioconjugation-based Nonviral RNA Delivery Technologies to Gain Momentum in the Next 3 Years
RNA therapeutics is a rapidly expanding field of next-generation medicine. RNA therapy typically comprises 4 different classes of molecules: non-codingRNA (ncRNA), antisense oligonucleotide (ASO), messengerRNA (mRNA), and RNA aptamer. Small ncRNAs are like a double-edged sword; they can either up- or down-regulate specific genes. Contrarily, long...
$4,950.00